T2 Biosystems, Inc. announced preliminary revenue results for the fourth quarter ended December 31, 2019. Fourth quarter total revenue of approximately $3.0 million, an increase of 67% compared to the prior year period. Fourth quarter product revenue of approximately $1.5 million, an increase of 15% compared to the prior year period.